Vogt Frederick G 4

4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Jun 9, 2026

AI-generated summary of this filing

Updated Jun 9, 2026

IOVANCE CEO Frederick Vogt Receives RSUs — 24,612 Net Shares

What Happened

Frederick G. Vogt, Interim CEO & General Counsel and a director of Iovance Biotherapeutics (IOVA), had restricted stock units (RSUs) vest on June 5, 2026. A total of 31,250 RSUs converted into common stock (reported as derivative exercises, code M) at an acquisition price of $0.00 per share.
To satisfy mandatory tax withholding, 6,638 shares were withheld (code F) at a withholding price of $4.23 per share, totaling $28,079. After withholding, Vogt received a net 24,612 shares added to his holdings. The withholding was not an open-market sale.

Key Details

Transaction date: 2026-06-05; Form 4 filed 2026-06-09 (timely within the two-business-day reporting window).
Conversion: 31,250 RSUs -> 31,250 shares (reported as two M entries of 15,625 each).
Tax withholding: 6,638 shares withheld at $4.23/share = $28,079 (reported as F; not an open-market sale).
Net shares received: 31,250 − 6,638 = 24,612 shares.
Footnotes: RSUs vested on the transaction date; each RSU converts to one share. Withheld shares satisfy mandatory tax withholding (not a sale). Remaining RSUs from the March 5, 2025 grant will continue to vest in equal quarterly installments.
Shares owned after transaction: not specified in the provided filing excerpt.

Context

This transaction reflects RSU vesting and conversion to common stock (an award vesting), not a market purchase or sale. The withholding to cover taxes is routine and does not indicate an open-market sale of shares.

Form 4

Period: 2026-06-05

DirectorInterim CEO & General Counsel

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-06-05+15,625→ 569,130 total
Tax Payment
Common Stock
[F2][F3]
2026-06-05$4.23/sh−6,638$28,079→ 562,492 total
Exercise/Conversion
Restricted Stock Units
[F4][F5][F6]
2026-06-05−15,625→ 109,382 total
→ Common stock (15,625 underlying)

Footnotes (6)

[F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
[F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
[F3]Represents common stock remaining after deducting the common stock withheld for taxes.
[F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
[F5]The remaining RSUs will vest in equal quarterly installments.
[F6]Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.

Signature

/s/ Frederick G. Vogt|2026-06-09

1 file